Subscribe to RSS

DOI: 10.1055/s-0045-1812029
Impact of weight loss and disease progression on survival in ALS: insights from a multidisciplinary care center
Authors
Funding This research was conducted with the internal support of UFRN and HUOL. No external funding or grants were received for this study.
Abstract
Background
Amyotrophic lateral sclerosis (ALS) is a multifaceted neurodegenerative disorder with a poor prognosis. Weight loss and malnutrition emerge as significant clinical features during disease progression.
Objective
To explore how demographic and clinical characteristics relate to survival in ALS patients, emphasizing the role of weight loss percentage at the time of diagnosis.
Methods
We conducted a retrospective study that used the database of a multidisciplinary ALS care center in the city of Natal, Brazil.
Results
A total of 132 patients were included in the study. The mean age of the participants at symptom onset was of 56.9 years, and most of them were male (59.8%). Older age, bulbar onset, and faster disease progression were associated with weight loss ≥ 10% at diagnosis. Among 132 patients, 72% experienced death or tracheostomy, with a median survival of 34 months. Survival was notably reduced in patients aged ≥ 60 years, those with significant weight loss, rapid disease progression, or those submitted to gastrostomy. Weight loss and the rate of disease progression were the strongest predictors of reduced survival. Potential factors relating gastrostomy with reduced survival are discussed.
Conclusion
The present study highlights the critical impact of weight loss and disease progression on survival in ALS patients, emphasizing the importance of early nutritional and clinical interventions. These findings underscore the need for comprehensive, multidisciplinary care strategies to address key prognostic factors and improve outcomes in ALS patients.
Keywords
Amyotrophic Lateral Sclerosis - Weight Loss - Disease Progression - Nutritional Status - Survival AnalysisAuthors' Contributions
Conceptualization: METDJ; Data curation: METDJ, GCS, LLL; Formal analysis: METDJ, LCD, LLL; Methodology: METDJ, SHLV, LLL; Supervision: GCS, LLL; Writing – original draft: LCD, LLL; Writing – review & editing: METDJ, LCD, GCS, SHLV, LLL.
Data Availability Statement
The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Editor-in-Chief: Ayrton Roberto Massaro (https://orcid.org/0000-0002-0487-5299).
Associate Editor: Wilson Marques Jr. (https://orcid.org/0000-0002-4589-2749).
Publication History
Received: 22 January 2025
Accepted: 27 July 2025
Article published online:
15 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Mário Emílio Teixeira Dourado Junior, Laura Carvalheira Dourado, Glauciane Costa Santana, Sancha Helena de Lima Vale, Lucia Leite-Lais. Impact of weight loss and disease progression on survival in ALS: insights from a multidisciplinary care center. Arq Neuropsiquiatr 2025; 83: s00451812029.
DOI: 10.1055/s-0045-1812029
-
References
- 1 Van Eenennaam RM, Kruithof WJ, Van Es MA, Kruitwagen-van Reenen ET, Westeneng H-J, Visser-Meily JMA. et al. Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide. BMC Neurol 2020; 20 (01) 446
- 2 Nelson AT, Trotti D. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 2022; 19 (04) 1102-1118
- 3 Van Mantgem MRJ, Van Eijk RPA, Van der Burgh HK, Tan HHG, Westeneng H-J, Van EsMA. et al. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2020; 91 (08) 867-875
- 4 Oliveira RTGd, Santana GC, Gonçalves MdJ, Fregonezi GAdF, Vale SHdL, Leite-Lais L, Dourado Júnior MET. A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to 2018. Amyotroph Lateral Scler Frontotemporal Degener 2023; 24 (1-2): 117-124
- 5 Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1 (05) 293-299
- 6 Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. BDNF ALS Study Group (Phase III). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999; 169 (1-2): 13-21
- 7 Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H. et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006; 66 (02) 265-267
- 8 Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999; 53 (05) 1059-1063
- 9 Limousin N, Blasco H, Corcia P, Gordon PH, De Toffol B, Andres C, Praline J. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. J Neurol Sci 2010; 297 (1-2): 36-39
- 10 Pandya VA, Patani R. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective. Brain 2020; 143 (04) 1057-1072
- 11 Mezoian T, Belt E, Garry J, Hubbard J, Breen CT, Miller L. et al. Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Muscle Nerve 2020; 61 (02) 230-234
- 12 Onesti E, Schettino I, Gori MC, Frasca V, Ceccanti M, Cambieri C. et al. Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management. Front Neurol 2017; 8: 94
- 13 Silva HFLd, Brito ANA, Freitas EPSd, Dourado Jr MET, Sena-Evangelista KCM, Lais LL. Dietary intake and zinc status in amyotrophic lateral sclerosis. Nutr Hosp 2017; 34 (05) 1361-1367
- 14 Kurihara M, Bamba S, Yasuhara S, Itoh A, Nagao T, Nakanishi N. et al. Factors Affecting Energy Metabolism and Prognosis in Patients with Amyotrophic Lateral Sclerosis. Ann Nutr Metab 2021; 77 (04) 236-243
- 15 Kasarskis EJ, Tandan R. Why is nutrition vital for advancing ALS care and clinical research?. Amyotroph Lateral Scler Frontotemporal Degener 2023; 24 (5-6): 359-361
- 16 Burgos R, Bretón I, Cereda E, Desport JC, Dziewas R, Genton L. et al. ESPEN guideline clinical nutrition in neurology. Clin Nutr 2018; 37 (01) 354-396
- 17 Boostani R, Olfati N, Shamshiri H, Salimi Z, Fatehi F, Hedjazi SA. et al. Iranian clinical practice guideline for amyotrophic lateral sclerosis. Front Neurol 2023; 14: 1154579
- 18 Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F. et al; Piemonte and Valle d'Aosta Register for ALS (PARALS). Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry 2019; 90 (06) 666-673
- 19 Moura MC, Novaes MRCG, Eduardo EJ, Zago YSSP, Freitas RdNB, Casulari LA. Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study. PLoS One 2015; 10 (10) e0141500
- 20 Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005; 25 (03) 114-119
- 21 Pupillo E, Messina P, Logroscino G, Beghi E. SLALOM Group. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 2014; 75 (02) 287-297
- 22 Forbes RB, Colville S, Swingler RJ. Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 2004; 33 (02) 131-134
- 23 Bianchi E, Pupillo E, De Feudis A, Enia G, Vitelli E, Beghi E. Trends in survival of ALS from a population-based registry. Amyotroph Lateral Scler Frontotemporal Degener 2022; 23 (5-6): 344-352
- 24 Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M. et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2011; 82 (06) 628-634
- 25 Dandaba M, Couratier P, Labrunie A, Nicol M, Hamidou B, Raymondeau M. et al; FRALIM Consortium. Characteristics and Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis. Neuroepidemiology 2017; 49 (1-2): 64-73
- 26 Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci 2011; 304 (1-2): 44-48
- 27 Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS One 2017; 12 (05) e0177555
- 28 Sulistyo A, Abrahao A, Freitas ME, Ritsma B, Zinman L. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2023; 8 (08) CD004030
- 29 Son B, Lee J, Ryu S, Park Y, Kim SH. Timing and impact of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis: a comprehensive analysis. Sci Rep 2024; 14 (01) 7103
- 30 Vergonjeanne M, Fayemendy P, Marin B, Penoty M, Lautrette G, Sourisseau H. et al. Predictive factors for gastrostomy at time of diagnosis and impact on survival in patients with amyotrophic lateral sclerosis. Clin Nutr 2020; 39 (10) 3112-3118
- 31 White S, O'Cathain A, Halliday V, Croot L, McDermott CJ. Factors influencing decisions people with motor neuron disease make about gastrostomy placement and ventilation: A qualitative evidence synthesis. Health Expect 2023; 26 (04) 1418-1435
- 32 Gaspar R, Ramalho R, Coelho R, Andrade P, Goncalves MR, Macedo G. Percutaneous Endoscopic Gastrostomy Placement under NIV in Amyotrophic Lateral Sclerosis with Severe Ventilatory Dysfunction: A Safe and Effective Procedure. GE Port J Gastroenterol 2021; 30 (01) 61-67
- 33 Thompson AG, Blackwell V, Marsden R, Millard E, Lawson C, Nickol AH. et al. A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2017; 18 (3-4): 243-248
- 34 López-Gómez JJ, Ballesteros-Pomar MD, Torres-Torres B, Pintor-De la Maza B, Penacho-Lázaro MA, Palacio-Mures JM. et al. Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS). Nutrients 2021; 13 (08) 2765
- 35 Kotsia E, Chroni E, Alexandropoulou A, Mills C, Veltsista D, Kefalopoulou ZM, Michou E. Dysphagia Assessments as Criteria in the ‘Decision-Making Process’ for Percutaneous Endoscopic Gastrostomy Placement in People with Amyotrophic Lateral Sclerosis: A Systematic Review. Dysphagia 2024; 39 (06) 977-988
- 36 Orlandoni P, Jukic Peladic N. Safety and Effectiveness of Percutaneous Endoscopic Gastrostomy May Be Improved by Proper Pre- and Post-Positioning Management of Elderly Patients with Multimorbidity. Nutrients 2024; 16 (17) 2893
- 37 ProGas Study Group. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol 2015; 14 (07) 702-709
- 38 Wanden-Berghe C, Patino-Alonso MC, Galindo-Villardón P, Sanz-Valero J. Complications Associated with Enteral Nutrition: CAFANE Study. Nutrients 2019; 11 (09) 2041
- 39 Franca SC, Paiva SARd, Borgato MH, Fontes CMB, Simonetti JP, Lima SAM, Papini SJ. Homemade diet versusdiet industrialized for patients using alternative feeding tube at home - An integrative review. Nutr Hosp 2017; 34 (05) 1281-1287
- 40 Wang S, Yuan T, Yang H, Zhou X, Cao J. Effect of complete high-caloric nutrition on the nutritional status and survival rate of amyotrophic lateral sclerosis patients after gastrostomy. Am J Transl Res 2022; 14 (11) 7842-7851
